Back to Rankings

TRLV

Trulieve CannabisC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-08-06
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
20%
Probability
Target price
$11.50
+27.8% vs current
Most likely
B
Base case
55%
Probability
Target price
$8.75
-2.8% vs current
B-
Bear case
25%
Probability
Target price
$6.25
-30.6% vs current

AI sentiment snapshot

Latest data as of 2026-08-06
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+54.8
Score

AI commentary

Evidence quality is strong on recent company filings, but forward visibility remains limited. The near-term focus is the scheduled Q2 report and call; analyst revisions, consensus surprise data, and post-release market reaction are not yet available. Recent news coverage is sparse, and insider selling adds caution. This remains a monitoring setup rather than a high-conviction directional thesis.

RankAlpha Sentiment Codex - 2026-08-06
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-08-05eventDelaware domestication vote approvedMedium impact

Shareholders approved the Delaware domestication proposal at the August 5 special meeting, reducing a corporate-structure uncertainty, although the direct operating and valuation impact is unclear. [#8-K-2026-08-05]

2026-08-07catalystQ2 2026 results are the key near-term confirmation testMedium impact

Trulieve scheduled its Q2 2026 results release and conference call for August 7. Investors will look for confirmation that Q1 profitability and cash generation can persist despite year-over-year and sequential revenue declines. [#PR-EARNINGS-2026-07-10] [#SEC-8K-2026-05-07]

2026-09-30eventFederal cannabis rescheduling implementation remains a swing factorHigh impact

Management reported that medical marijuana was reclassified to Schedule III and that the company filed DEA registration applications covering 206 retail locations. Benefits remain conditional on implementation, scope, and timing. [#SEC-8K-2026-05-07]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-08-06 • Updated nightlySource: Internal modelMethodology